Capital Group Ultra Short Income ETF (CGUI) Quote

correction 1955

Rose, they don't have to do a reverse split and I could care less if they get delisted from the Nasdaq. I bought a stock and still have it called Luckin Coffee Luckin Coffee Inc. (LKNCY)...... they were up to $50/sh if I remember correctly and they got my attention when the stock took a dive down

Very impressive results .

Bear trap to .0019 & then 15M BID:-) Nice game.

$DBMM

It doesn't matter if it's factual info or gut feelings/personal opinions he will delete it..

I believe a whole pile of ignorance drove up tonight and be
trying to scam somebody with half a load of BS cause they
know what is about to happen with WDLF. That just me tho!

MoronMan is speechless

https://x.com/sahilkapur/status/1818849276266475833?s=19

I don’t always respond to the stupidity but sometimes it’s entertaining

That's like 99% of your posts and I agree it's entertaining. Thank you for your service.

Maybe he’s a sociopathic liar we may need to have him get medical examination?

Hello, docsetc.

In your most recent response to me, you said that you and your brother, a lawyer, wanted to see the agreement that I had signed to invest into BioClonetics.

Well, the agreement appears at the following link:
https://www.sec.gov/Archives/edgar/data

Wait, are you submitting a resume?
How come your mom hasn't locked your tablet? Time for beddy bye, wittle shoo shoo..

Safe?

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/453207456_906201561549224_1971378753254258061_n.jpg?_nc_cat=105&ccb=1-7&_nc_sid=833d8c&_nc_ohc=Esj_-ZaAJNkQ7kNvgH_Qxh4&_nc_ht=scontent-sea1-1.xx&oh=00_AYBIOud-dkSBiMwB6F1e-ESSTZzp2AAbXMHejaggRr_PhA&oe=66B0D77E

htt

Let’s just say one day it will all come together

For one the sugar is a killer. No wonder obesity is a problem.

The rest of the ingredients, and the way they're combined, would kill you MUCH faster.

Market is overbought!! Just keeping options unpredictable!! Will head back towards 100!!

Wasn’t watching today but wow, dropped all the way down to .0019. What a lack of confidence in Linda and Reggie. They sure can’t seem to do anything right. I still love the idea of them hosting a shareholders meeting where we can ask them anything we want. My goodness they must be humiliated at how

Capt'n Independent Study is back......when are you going to give this up Kiwi? Do you realize the reason the EU gave AMRN exclusivity until 2039 was because of the Reduce-It study results? The reason certain countries are dragging their feet on reimbursement is because they can. They'll use whate

BTW "New Boeing" will be HQ'd again in Seattle.

The DEA might reclassify cannabis, removing it from the list of schedule-1 drugs. This would enable the FDA to conduct medical research, and allow insurance companies to assist patients by lowering the overall cost of medical cannabis. This could be achieved through a co-pay system similar to what i

Says the one asking for a detailed answer on something he knows is private, yet won’t answer an easy question with the answers clearly posted in the board box.

🤡🤡🤡🤡🤡🤡

people look at share price and assume it is cheap. Look at the market cap (shares outstanding x share price), and this thing certainly ain't cheap sitting at 500M with no cash to their name. Cheap for bio is when your market cap trades below your cash value....that is cheap. This thing has 1.2

If the DEA reclassifies cannabis and takes it off the schedule-1 drugs list, the FDA could study it for medical uses. This would also allow insurance companies to help patients reduce the cost of medical cannabis, using a co-pay system like the one for pharmacy prescriptions.

$MSOS $M

BEST SELLERS RANK (BSR) IS 747 21 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value De

The potential reclassification of cannabis by the DEA, removing it from the schedule-1 drugs list, could significantly impact both medical research and patient access. By allowing the FDA to thoroughly study cannabis for its medical applications, we could see more evidence-based treatments emerge. A

Quality is not a luxury and AIRI is quality. So I buy more shares as nothing is as underpriced as this company. Re creating this company would cost much more than $3.68 per share. The insiders know what the company is worth and they have been buying.